Breast cancer and immunology: biomarker and therapeutic developments.

about

Treating breast cancer with cell-based approaches: an overview.A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer.

P2860

Q39448180-E707450D-DC9B-4908-A857-458B6EA73722 Q53069347-9097CE15-F4EC-4DFA-B686-7E6D3E3FF9D0

P2860

Breast cancer and immunology: biomarker and therapeutic developments.

Item

http://www.wikidata.org/entity/Q38584383

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Breast cancer and immunology: biomarker and therapeutic developments.

@en

type

Item

label

Breast cancer and immunology: biomarker and therapeutic developments.

@en

prefLabel

Breast cancer and immunology: biomarker and therapeutic developments.

@en

P1476

Breast cancer and immunology: biomarker and therapeutic developments.

@en

P2093

Cesar A Santa-Maria

http://www.w3.org/2001/XMLSchema#string

Sarika Jain

http://www.w3.org/2001/XMLSchema#string

Sue Jung Park

http://www.w3.org/2001/XMLSchema#string

William J Gradishar

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

Cancer immunoediting: from immunosurveillance to tumor escape

The three Es of cancer immunoediting

Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

P304

1215-1222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.2015.1086270

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26358181

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

Breast cancer and immunology: biomarker and therapeutic developments.

about

P2860

P2860

Breast cancer and immunology: biomarker and therapeutic developments.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921